ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,404 | -74.2% | 41,000 | 0.0% | 0.00% | – |
| Q2 2023 | $20,910 | -20.5% | 41,000 | -1.8% | 0.00% | – |
| Q1 2023 | $26,303 | -2.9% | 41,750 | 0.0% | 0.00% | – |
| Q4 2022 | $27,100 | -61.3% | 41,750 | +2.5% | 0.00% | -100.0% |
| Q3 2022 | $70,000 | +70.7% | 40,750 | +23.5% | 0.00% | – |
| Q2 2022 | $41,000 | -10.9% | 33,000 | -53.5% | 0.00% | – |
| Q1 2022 | $46,000 | -37.8% | 71,000 | +4.8% | 0.00% | -100.0% |
| Q4 2021 | $74,000 | -40.3% | 67,780 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $124,000 | +69.9% | 67,780 | +144.0% | 0.00% | 0.0% |
| Q2 2021 | $73,000 | -27.0% | 27,780 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $100,000 | +42.9% | 27,780 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | 0.0% | 27,780 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $70,000 | +677.8% | 27,780 | +1041.8% | 0.00% | – |
| Q1 2018 | $9,000 | -40.0% | 2,433 | 0.0% | 0.00% | – |
| Q1 2017 | $15,000 | +15.4% | 2,433 | 0.0% | 0.00% | – |
| Q4 2016 | $13,000 | – | 2,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |